View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Pulmonary Vascular Disease News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 23, 2023
3 min read
Save

Low income linked to more severe chronic thromboembolic pulmonary hypertension

Low income linked to more severe chronic thromboembolic pulmonary hypertension

HONOLULU — Patients with chronic thromboembolism pulmonary hypertension and a higher median income had better 6-minute walk distance and hemodynamics than those with a low income, according to a presentation at the CHEST Annual Meeting.

SPONSORED CONTENT
October 17, 2023
1 min read
Save

Diabetes may raise odds for mortality in pulmonary hypertension

Diabetes may raise odds for mortality in pulmonary hypertension

HONOLULU — Patients with pulmonary hypertension who also had diabetes showed increased likelihood for mortality compared with patients without diabetes, according to a systemic review presented at the CHEST Annual Meeting.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
October 11, 2023
3 min read
Save

ARDS plus pulmonary hypertension raises odds for mortality, longer hospital stay

ARDS plus pulmonary hypertension raises odds for mortality, longer hospital stay

HONOLULU — Patients with pulmonary hypertension hospitalized with acute respiratory distress syndrome had increased odds for mortality, extended stays and higher costs, according to research presented at the CHEST Annual Meeting.

SPONSORED CONTENT
October 10, 2023
2 min read
Save

Higher comorbidity burden raises odds for in-hospital mortality in patients with PE

Higher comorbidity burden raises odds for in-hospital mortality in patients with PE

HONOLULU — A higher comorbidity burden increases the odds for in-hospital mortality among adults with pulmonary embolism, according to a poster presented at the CHEST Annual Meeting.

SPONSORED CONTENT
September 28, 2023
1 min read
Save

FDA grants priority review to sotatercept for pulmonary arterial hypertension

FDA grants priority review to sotatercept for pulmonary arterial hypertension

The FDA has granted priority review to sotatercept, a novel activin signaling inhibitor designed to treat adults with pulmonary arterial hypertension, according to a manufacturer-issued press release.

SPONSORED CONTENT
September 20, 2023
2 min read
Save

Ultrasound lowers diagnostic imaging referral in suspected PE, but has high failure rate

Ultrasound lowers diagnostic imaging referral in suspected PE, but has high failure rate

Referral to diagnostic imaging decreased with use of an ultrasound protocol in patients with suspected pulmonary embolism, according to a presentation at the European Respiratory Society International Congress.

SPONSORED CONTENT
September 14, 2023
2 min read
Save

Flu season ups CV risk, not reduced by higher-dose vaccine in already high-risk patients

Flu season ups CV risk, not reduced by higher-dose vaccine in already high-risk patients

Local influenza spread was associated with temporary increased CV risk, but flu vaccine dose — high or standard — did not prevent hospitalization for cardiopulmonary events or all-cause death in high-risk patients, researchers reported.

SPONSORED CONTENT
September 13, 2023
2 min read
Save

Sotatercept expected to raise life expectancy, lower hospitalizations in PAH

Sotatercept expected to raise life expectancy, lower hospitalizations in PAH

Patients with pulmonary arterial hypertension receiving sotatercept, a novel activin signaling inhibitor, plus background therapy are expected to live longer, according to a European Respiratory Society International Congress presentation.

SPONSORED CONTENT
August 24, 2023
3 min read
Save

One in 10 patients in cardiac ICU uses recreational drugs; half fail to disclose it

One in 10 patients in cardiac ICU uses recreational drugs; half fail to disclose it

Use of recreational drugs such as cannabis, opioids, cocaine and amphetamines was prevalent in 11% of patients admitted to French cardiac ICUs and tied to increased odds of in-hospital major adverse events, researchers reported.

SPONSORED CONTENT
August 22, 2023
3 min read
Save

Workshop aims to expand use of point-of-care ultrasonography

Workshop aims to expand use of point-of-care ultrasonography

With its noninvasive and portable nature, point-of-care ultrasonography is an emerging technological tool for critical care clinicians when diagnosing and caring for patients.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails